Heping Yang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Liver physiology and pathology
Papers in
- Oncology 7
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Kwang Suk Ko (5 shared papers)Zong‐Zhi Huang (3 shared papers)Shelly C. Lu (3 shared papers)Xiangdong Zhou (4 shared papers)Jian Peng (4 shared papers)María‐Angeles Aller (5 shared papers)Tony W.H. Li (1 shared paper)Xiaopeng Ou (2 shared papers)
- Journals
- Biochemical Journal (2 papers)Journal of Oncology (1 paper)Cancer Research (1 paper)Comparative and Functional Genomics (1 paper)Pathology & Oncology Research (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Heping Yang
24 papers receiving 494 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 114
- Hepatology 57
- Pharmacology 38
- Biochemistry 30
- Molecular Medicine 19
Countries citing papers authored by Heping Yang
This map shows the geographic impact of Heping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Yang more than expected).
Fields of papers citing papers by Heping Yang
This network shows the impact of papers produced by Heping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Yang. The network helps show where Heping Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Heping Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 106 | |
| 2 | 2015 | 61 | |
| 3 | 2012 | 56 | |
| 4 | 1999 | 51 | |
| 5 | 2001 | 45 | |
| 6 | 2012 | 35 | |
| 7 | 2001 | 29 | |
| 8 | 2012 | 26 | |
| 9 | 2015 | 19 | |
| 10 | 2013 | 14 | |
| 11 | 2011 | 8 | |
| 12 | CA916798 regulates multidrug resistance of lung cancer cells. | 2011 | 8 |
| 13 | 2012 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2013 | 6 | |
| 16 | 2020 | 4 | |
| 17 | 2012 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2013 | 3 | |
| 20 | 2024 | 2 |
About Heping Yang
Heping Yang is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Pharmacology, having authored 24 papers that have together received 499 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (3 papers), MicroRNA in disease regulation (3 papers), Sulfur Compounds in Biology (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Urban Transport and Accessibility (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (114 citations), Hepatology (57 citations), Pharmacology (38 citations), Biochemistry (30 citations) and Molecular Medicine (19 citations). Heping Yang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Kwang Suk Ko, Zong‐Zhi Huang, Shelly C. Lu, Xiangdong Zhou, Jian Peng, María‐Angeles Aller, Tony W.H. Li, Xiaopeng Ou, Yu Zhou and Meng Xia. Their work appears in journals such as Biochemical Journal, Journal of Oncology, Cancer Research, Comparative and Functional Genomics and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.